Related Experiment Video
Updated: Aug 6, 2026

An Electroporation Method to Transform Rickettsia spp. with a Fluorescent Protein-Expressing Shuttle Vector in Tick Cell Lines
Published on: October 11, 2022
A flea-associated Rickettsia pathogenic for humans
1Unité des Rickettsies, CNRS UPRESA 6020, Faculté de Médecine, Université de la Méditerranée, 27 Bd Jean Moulin, 13385 Marseille, France. Didier.Raoult@medecine.univ-mrs.fr
Abstract:
A rickettsia named the ELB agent, or "Rickettsia felis," was identified by molecular biology techniques in American fleas in 1990 and later in four patients from Texas and Mexico. We attempted to isolate this rickettsia from infected fleas at various temperatures and conditions. A representative isolate of the ELB agent, the Marseille strain, was characterized and used to develop a microimmunofluorescence test that detected reactive antibodies in human sera. The ELB agent was isolated from 19 of 20 groups of polymerase chain reaction-proven infected fleas. The microimmunofluorescence results provided serologic evidence of infection by the ELB agent in four patients with fever and rash in France (2) and Brazil (2), supporting the pathogenic role of this rickettsia. Our successful isolation of this rickettsia makes it available for use in serologic tests to determine its clinical spectrum, prevalence, and distribution.
Insights
Researchers isolated Rickettsia felis, the ELB agent, from fleas and patients, confirming its role in causing fever and rash. This discovery enables further studies on its prevalence and distribution.
Area of Science:
- Microbiology
- Infectious Diseases
- Vector-borne Illnesses
Background:
- The ELB agent, identified as Rickettsia felis, was first detected in American fleas in 1990.
- Initial findings linked Rickettsia felis to human cases in Texas and Mexico, suggesting a potential public health concern.
Purpose of the Study:
- To successfully isolate Rickettsia felis from infected fleas under various laboratory conditions.
- To characterize an isolate and develop a serological assay for detecting human antibodies.
- To provide serological evidence supporting the pathogenic role of Rickettsia felis in human illness.
Main Methods:
- Isolation of the ELB agent (Marseille strain) from infected fleas.
- Characterization of the isolated rickettsia.
- Development of a microimmunofluorescence (MIF) test for antibody detection.
- Polymerase chain reaction (PCR) used to confirm flea infection.
Main Results:
- Successful isolation of the ELB agent from 19 out of 20 PCR-confirmed infected flea groups.
- The developed MIF test detected reactive antibodies in human sera.
- Serological evidence of ELB agent infection was found in four patients presenting with fever and rash in France and Brazil.
Conclusions:
- The study successfully isolated Rickettsia felis, confirming its etiological role in human febrile illness.
- The availability of an isolated strain and a developed serological test facilitates further research.
- Future research can now focus on determining the clinical spectrum, prevalence, and geographical distribution of Rickettsia felis infections.
Related Concept Videos
Intracellular Movement of Viruses and Bacteria
Bacterial Phylum Spirochaetes
Rocky Mountain Spotted Fever
Plague
Rabies
Leishmaniasis

